she was in the hospital with the blood pressure of 252/190; myocarditis; optic nerve swelling; severe bruising; migraines; exhaustion; petechiae on her back; cotton wool spots on her eye; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 21-year-old female patient received BNT162b2 (BNT162B2), on 11May2022 as dose 2, single (Lot number: FK9894) at the age of 21 years for covid-19 immunisation. The patient's relevant medical history included: "Covid-19", start date: Sep2020 (unspecified if ongoing), notes: had covid in Sep2020 and then again this year Jan/Feb2022 and then was vaccinated in Apr.; "Covid-19", start date: 2022 (unspecified if ongoing), notes: had covid in Sep2020 and then again this year Jan/Feb2022 and then was vaccinated in Apr. The patient took concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot: FK9894), administration date: 20Apr2022, when the patient was 21-year-old, for COVID-19 immunization, reaction(s): "Hypertensive crisis", "bruising", "headaches", "visual changes", "slowing of optic nerve". The following information was reported: HYPERTENSIVE CRISIS (hospitalization, medically significant) with onset 23Jun2022, outcome "unknown", described as "she was in the hospital with the blood pressure of 252/190"; MYOCARDITIS (medically significant), outcome "unknown"; PAPILLOEDEMA (medically significant), outcome "unknown", described as "optic nerve swelling"; CONTUSION (non-serious), outcome "unknown", described as "severe bruising"; MIGRAINE (non-serious), outcome "unknown", described as "migraines"; FATIGUE (non-serious), outcome "unknown", described as "exhaustion"; PETECHIAE (non-serious), outcome "unknown", described as "petechiae on her back"; RETINAL EXUDATES (non-serious), outcome "unknown", described as "cotton wool spots on her eye". The patient underwent the following laboratory tests and procedures: Blood pressure measurement: 252/190; 252, notes: (hospital name withheld and the hospital (withheld) ran multiple tests and they couldn't find any reason for her blood pressure to go from normal to 252; Computerised tomogram: Unknown results; Magnetic resonance imaging: Unknown results; Urine analysis: Unknown results. Therapeutic measures were taken as a result of hypertensive crisis.  Clinical course: Patient received 2 doses of the Pfizer Covid vaccine. 1st dose on 20Apr2022, 2nd dose on 11May2022. On 23Jun2022 she went to the hospital in (hospital name withheld) and was admitted with a blood pressure of 252/190. She spent 5 days in ICU, and 3 days in a regular room. She had severe bruising on both legs and both arms, and petechiae on her back, migraines, and was severely exhausted. (hospital name withheld and the hospital (withheld) ran multiple tests and they couldn't find any reason for her blood pressure to go from normal to 252. They did a CAT scan, MRI's, and a 24 hour Urinalysis for her kidneys to check for adrenal gland tumors. Patient is a 21 year old athlete, that is now on 4 medications to control her blood pressure. States that they have been treating this as myocarditis. Caller believes all this was an adverse reaction to the vaccine. Has anyone else reported any of these effects after receiving this shot? Stated that it took the hospital 3 days of giving her daughter IV medications to get her blood pressure under control before she could go to oral medications.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201340703 same reporter/patient, different dose/AE;